FRONTIER BIOTECHNOLOGIES Inc.

PRODUCT

Long-acting peptide drug discovery and development platform
HOME>Product

3BNC117 is a novel broad-spectrum HIV neutralizing antibody targeting HIV-1 gp120 CD4 binding site.

Albuvirtide is a treatment-paradigm shifting long-acting HIV fusion inhibitor for treatment of HIV infection and AIDS

New transdermal patch for musculoskeletal pain

Develop innovative therapies to better human lives